Published in Biochem Biophys Res Commun on April 16, 1990
Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med (1999) 5.26
Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol (2007) 2.65
Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect Immun (1996) 1.59
Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons. Mol Cell Biol (1991) 1.52
Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts. Infect Immun (1994) 1.47
Inhibition of collagenase and stromelysin gene expression by interferon-gamma in human dermal fibroblasts is mediated in part via induction of tryptophan degradation. J Clin Invest (1995) 1.00
Purification and molecular cloning of rat 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase. Biochem J (2002) 0.98
Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection. J Infect Dis (2012) 0.95
The role of placental tryptophan catabolism. Front Immunol (2014) 0.88
Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice. ISME J (2015) 0.80
Depletion of tryptophan is not involved in expression of tryptophanyl-tRNA synthetase mediated by interferon. Infect Immun (1992) 0.79
The role of placental indoleamine 2,3-dioxygenase in human pregnancy. Obstet Gynecol Sci (2013) 0.76
Improving the safety of tolerance induction: chimerism and cellular co-treatment strategies applied to vascularized composite allografts. Clin Dev Immunol (2012) 0.75
Identification and Evaluation of New Immunoregulatory Genes in Mesenchymal Stromal Cells of Different Origins: Comparison of Normal and Inflammatory Conditions. Med Sci Monit Basic Res (2017) 0.75
Placental expression of indoleamine 2,3-dioxygenase. Wien Med Wochenschr (2012) 0.75
Nucleotide sequence of a ribosome attachment site of bacteriophage f2 RNA. Biochem Biophys Res Commun (1970) 2.32
Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc Natl Acad Sci U S A (1980) 2.24
Receptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21. Proc Natl Acad Sci U S A (1984) 1.86
Interferon action: induction of specific proteins in mouse and human cells by homologous interferons. Proc Natl Acad Sci U S A (1979) 1.76
Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-gamma-inducible expression of human indoleamine 2,3-dioxygenase gene. J Biol Chem (1996) 1.47
Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-gamma. Upstream control region discriminates between interferon-gamma and interferon-alpha. J Biol Chem (1990) 1.36
Movement of the ribosome along the messenger ribonucleic acid during protein synthesis. Biochemistry (1971) 1.30
Inhibition of protein synthesis directed by added viral and cellular messenger RNAs in extracts of interferon-treated Ehrlich ascites tumor cells. Location and dominance of the inhibitor(s). Biochem Biophys Res Commun (1973) 1.30
Differential regulation of a cellular gene by human interferon-gamma and interferon-alpha. J Biol Chem (1988) 1.23
Receptors for human gamma interferon: binding and crosslinking of 125I-labeled recombinant human gamma interferon to receptors on WISH cells. Proc Natl Acad Sci U S A (1984) 1.18
Interferon receptors. Cross-linking of human leukocyte interferon alpha-2 to its receptor on human cells. J Biol Chem (1982) 1.17
Interferon action against reovirus: activation of interferon-induced protein kinase in mouse L929 cells upon reovirus infection. Virology (1982) 1.17
Interferon-induced proteins in human fibroblasts and development of the antiviral state. J Virol (1980) 1.12
Interferon treatment of Ehrlich ascites tumor cells: effects on exogenous mRNA translation and tRNA inactivation in the cell extract. J Virol (1975) 1.11
Specific protein phosphorylation in interferon-treated uninfected and virus-infected mouse L929 cells: enhancement by double-stranded RNA. J Virol (1979) 1.11
Effect of growth hormone on ribonucleic acid metabolism. 3. Nature and characteristics of nuclear subfractions stimulated by hormone treatment. Biochem J (1964) 1.10
Involvement of two regulatory elements in interferon-gamma-regulated expression of human indoleamine 2,3-dioxygenase gene. J Interferon Cytokine Res (1995) 1.08
Release of the inhibition of messenger RNA translation in extracts of interferon-treated Ehrlich ascites tumor cells by added transfer RNA. Biochem Biophys Res Commun (1974) 1.05
Selective inhibition of viral protein accumulation in interferon-treated cells; nondiscriminate inhibition of the translation of added viral and cellular messenger RNAs in their extracts. Virology (1974) 1.04
Enhanced gel mobility shift assay for DNA-binding factors. Anal Biochem (1993) 1.01
Apparent changes in ribosome conformation during protein synthesis. Centrifugation at high speed distorts initiation, pretranslocaton, and posttranslocation complexes to a different extent. Biochemistry (1972) 1.00
Regulation of the stability of poly(I)xpoly(C)-induced human fibroblast interferon mRNA: selective inactivation of interferon mRNA and lack of involvement of 2',5'-oligo(A) synthetase activation during the shutoff of interferon production. Proc Natl Acad Sci U S A (1980) 0.97
Mechanism of action of pituitary growth hormone. Recent Prog Horm Res (1975) 0.93
Regulation of interferon action in human fibroblasts: transient induction of specific proteins and amplification of the antiviral response by antinomycin D. Virology (1981) 0.92
The incidence and outcome of intracranial haemorrhage in newborns with haemophilia: analysis of the Nationwide Inpatient Sample database. Haemophilia (2007) 0.91
Interferon-associated, dsRNA-dependent enzyme activities in a mutant 3T6 cell engaged in the semiconstitutive synthesis of interferon. Cell (1978) 0.86
Interferon action in human fibroblasts: induction of 2', 5'-oligoadenylate synthetase in the absence of detectable protein kinase activity. Arch Virol (1982) 0.85
Interferon receptor interaction. Internalization of interferon alpha 2 and modulation of its receptor on human cells. Eur J Biochem (1984) 0.85
Molecular cloning of a novel receptor tyrosine kinase, tif, highly expressed in human ovary and testis. Oncogene (1994) 0.85
Renal insufficiency after trauma and sepsis. A prospective functional and ultrastructural analysis. Arch Surg (1971) 0.83
ATP-dependent uptake of nitrate in Nostoc muscorum and inhibition by ammonium ions. Biochim Biophys Acta (1981) 0.82
Effect of a bovine lung surfactant protein isolate (SP-B/C) on egg phosphatidylglycerol acyl chain order in a lipid mixture with dipalmitoylphosphatidylcholine and palmitic acid. J Pharm Sci (1994) 0.81
Analysis of interferon-gamma resistant mutants that are possibly defective in their signaling mechanism. Mol Gen Genet (1991) 0.80
Localization of indoleamine 2,3-dioxygenase gene (INDO) to chromosome 8p12-->p11 by fluorescent in situ hybridization. Cytogenet Cell Genet (1993) 0.80
Sarcocystis infection in pigs of Hissar, Haryana, India and its transmission to dogs. Vet Parasitol (1984) 0.79
Effect of growth hormone on ribonucleic acid metabolism. The template activity of the chromatin and molecular species of ribonucleic acid synthesized after treatment with the hormone. Biochem J (1968) 0.78
Toxoplasma seroprevalence in animals in northern India. Int J Zoonoses (1985) 0.78
Toxoplasma prevalence and human occupational groups. Int J Zoonoses (1985) 0.77
Studies on the early interactions of growth hormone: effect in vitro on lipogenesis in adipose tissue. Endocrinology (1971) 0.77
Pulmonary lung surfactant synthetic peptide concentration-dependent modulation of DPPC and POPG acyl chain order in a DPPC:POPG:palmitic acid lipid mixture. Chem Phys Lipids (1994) 0.76
Receptors for human alpha interferon: are gangliosides involved? J Interferon Res (1984) 0.76
Studies on the nucleotide sequence of a ribosome attachment site of bacteriophage f2 RNA. Cold Spring Harb Symp Quant Biol (1969) 0.75
Cholesterol monohydrate dissolution rate studies in aqueous micellar solutions of alpha-(nonylphenyl)-omega-hydroxydeca(oxyethylene), n-alkylamines, and fatty acids. J Pharm Sci (1985) 0.75
Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: evaluation of three methods. Am J Health Syst Pharm (1995) 0.75
A rapid card agglutination test for toxoplasmosis. Trop Anim Health Prod (1980) 0.75
On the inhibition of interferon action by inhibitors of fatty acid cyclooxygenase. Virology (1982) 0.75
Prevalence of Toxoplasma antibodies in sheep and goats in India. Trop Anim Health Prod (1983) 0.75
Identification of interferon receptors by chemical cross-linking. Methods Enzymol (1986) 0.75
Cultivation of Toxoplasma gondii in lamb testicular cell culture. Indian J Med Res (1980) 0.75
Experimental toxoplasmosis in buffalo calves. Vet Parasitol (1982) 0.75
Inhibition of interferon secretion in human fibroblast by vinblastine. Arch Virol (1982) 0.75
Receptors for human interferon-alpha: two forms of interferon-receptor complexes identified by chemical cross-linking. Prog Clin Biol Res (1985) 0.75
Chemotherapeutic efficacy of some agents against experimental toxoplasmosis in mice. Indian J Med Res (1981) 0.75
Congenital ocular abnormalities of the new born. J Pediatr Ophthalmol Strabismus (1980) 0.75
Localization of the human indoleamine 2,3-dioxygenase (IDO) gene to the pericentromeric region of human chromosome 8. Genomics (1993) 0.75
On the movement of the ribosome along the messenger ribonucleic acid and on apparent changes in ribosome conformation during protein synthesis. Basic Life Sci (1973) 0.75
Cholesterol monohydrate dissolution rate studies in aqueous micellar sodium chenodeoxycholate solutions. J Pharm Sci (1985) 0.75
Radiolabeling of human leukocyte and immune interferons with 125I and lactoperoxidase. Methods Enzymol (1986) 0.75
Cell-mediated immunity in experimental toxoplasmosis. Indian J Med Res (1980) 0.75
Experimental Sarcocystis levinei infection in buffalo calves. Vet Parasitol (1986) 0.75